Skip to main content
SpringerLink
Log in

Lucinactant in neonatal respiratory distress syndrome: profile report

  • Drug and Profile Reports
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Moen MD, Perry CM, Wellington K. Lucinactant in neonatal respiratory distress syndrome. Treat Respir Med 2005: 4(2): 139–45

    Article  PubMed  CAS  Google Scholar 

  2. Moya FR. Lucinactant in neonatal respiratory distress syndrome: a viewpoint. Treat Respir Med 2005; 4(2): 146

    Article  Google Scholar 

  3. Sinha SK. Lucinactant in neonatal respiratory distress syndrome: a viewpoint. Treat Respir Med 2005; 4(2): 146–7

    Article  Google Scholar 

  4. Boyd S. Causes and treatment of neonatal respiratory distress syndrome. Nurs Times 2004 Jul; 100(30): 40–4

    Google Scholar 

  5. Suresh GK, Soll RF. Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents? Pediatr Drugs 2002; 4(8): 485–92

    Google Scholar 

  6. Moya F, Gadzinowski J, Bancalari E, et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome in very preterm infants. Pediatrics 2005 Apr; 115(4): 1018–29

    Article  PubMed  Google Scholar 

  7. Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 2005 Apr; 115(4): 1030–8

    Article  PubMed  Google Scholar 

  8. Cochrane CG, Revak SD, Merritt A, et al. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Am J Respir Crit Care Med 1996 Jan; 153: 404–10

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucinactant in neonatal respiratory distress syndrome: profile report. Drugs Ther. Perspect 21, 5–6 (2005). https://doi.org/10.2165/00042310-200521100-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200521100-00002

Search

Navigation